# Treatment of Palmar Plantar Erythrodysesthesia (PPE) With Topical Sildenafil

> **NCT01219023** · PHASE1 · COMPLETED · sponsor: **Duke University** · enrollment: 10 (actual)

## Conditions studied

- Hand Foot Syndrome
- Palmar Plantar Erythrodysesthesia

## Interventions

- **DRUG:** sildenafil citrate

## Key facts

- **NCT ID:** NCT01219023
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2012-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01219023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01219023, "Treatment of Palmar Plantar Erythrodysesthesia (PPE) With Topical Sildenafil". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01219023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*